Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘18
126
17 22 5 19.5%
127
17 69 52 298%
128
17 30 13 32.1%
NTLA icon
129
Intellia Therapeutics
NTLA
$1.59B
17 44 27 36.3%
130
17 49 32 15.8%
131
17 71 54 57.6%
132
17 33 16 99.3%
133
17 73 56 53.3%
134
17 56 39 77.8%
135
17 55 38 26.4%
ETG
136
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.67B
17 36 19 30.7%
137
17 32 15 77.9%
138
17 92 75 31.5%
139
17 27 10 36.9%
140
17 54 37 23.6%
141
17 41 24 70%
142
17 57 40 6.3%
143
17 42 25 14.6%
144
16 18 2 30.8%
145
16 35 19 15.6%
146
16 58 42 14.4%
147
16 20 4 326%
148
16 29 13 16.5%
149
16 60 44 116%
150
16 18 2 34.4%